Is anyone here worried that the company has only 1-2 quarters of cash left in the bank at current average spend rates? Could another capital raise or further dilution in the very near future be on the cards?
It's great to see revenues increase, but when these are loss-making revenues (as is currently the case), and with limited cash on hand, it could spell disaster.
Looking at the last quarterly, the $413k in revenue cost the company $3.33M (if we exclude R&D, it still cost the company $2.2M). Even worse, the cost of sales alone exceeded the total revenues which demonstrates toxic Gross Margins ($916k COGS vs $413k Revenue) [September Quarterly Report - 31/10/19, pg. 7]
MXC Price at posting:
3.5¢ Sentiment: None Disclosure: Not Held
